Candida auris is a multidrug-resistant fungal pathogen that is associated with nosocomial outbreaks in patients with extensive health care exposure and treatment outside the United States. The Ohio Department of Health recommends C auris screening in high-risk patients. However, this can be operationally difficult for many health care facilities. This report describes a C auris and carbapenem-resistant Enterobacterales inpatient screening program done in collaboration with state public health.
Keyphrases
- public health
- healthcare
- multidrug resistant
- candida albicans
- mental health
- end stage renal disease
- palliative care
- ejection fraction
- newly diagnosed
- global health
- chronic kidney disease
- tertiary care
- biofilm formation
- drug resistant
- quality improvement
- acute care
- risk assessment
- patient reported
- climate change
- patient reported outcomes
- smoking cessation
- health insurance
- health promotion
- affordable care act